Adverse Event Reporting

Adverse event reporting is a critical post-market surveillance obligation in cosmetic regulation. It requires manufacturers and responsible persons to notify regulatory authorities when they become aware of harmful health effects associated with their products.

Under MoCRA in the US, the responsible person must report serious adverse events to the FDA within 15 business days of receiving the initial report, using FDA Form 3500A (MedWatch). The responsible person must also submit any new medical information received within one year of the initial report. Records of all adverse events (serious and non-serious) must be maintained for six years.

Under the EU Cosmetics Regulation (EC 1223/2009), the Responsible Person and distributors must report serious undesirable effects (SUEs) to the competent authority of the member state where the effect occurred. The Responsible Person must also report SUEs to the competent authorities of other member states where the product is marketed. There is no fixed calendar deadline in the EU — reports must be made "without delay."

Effective adverse event systems include consumer complaint intake procedures, medical evaluation protocols to assess severity, regulatory reporting workflows to meet deadlines, and trend analysis to identify emerging safety signals across product lines.